Arthritis Drugs in the Medical Literature This Month - February 2006
February 28, 2006
| Reduction in the Risk of Human Breast Cancer By Selective Cyclooxygenase-2 (COX-2) Inhibitors |
Journal: BMC Cancer 2006 Jan 30;6(1):27
Authors: R.E. Harris, J. Beebe-Donk, G.A. Alshafie
Summary: This case-control study examining 323 breast cancer patients aimed to compare the effects of selective and non-selective COX-2 inhibitors incident rates. The results showed significant risk reductions for selective COX-2 inhibitors as a group, with an odds ratio of 0.29; regular aspirin, with an odds ratio of 0.49; and ibuprofen or naproxen, with an odds ratio of 0.36. Acetominophen and low dose aspirin produced no …
UPCOMING CONFERENCES
HarrisMartin's Webinar Series: Water Contamination Litigation Presented by EisnerAmper
May 06, 2025